Literature DB >> 22886438

Clear cell sarcoma expressing a novel chimerical transcript EWSR1 exon 7/ATF1 exon 6.

Egle Gineikiene1, Dmitrij Seinin, Birute Brasiuniene, Andrius Brazaitis, Laimonas Griskevicius, Arturas Jakubauskas.   

Abstract

Clear cell sarcoma harbours recurrent translocation, resulting in EWSR1/ATF1 or less commonly EWSR1/CREB1 fusion. To date, six types of EWSR1/ATF1 fusion have been reported, of which three are in-frame and encode functional proteins. We present a reverse transcription - polymerase chain reaction analysis of a tumour near the hallux of the right foot. The sequencing of obtained fragments revealed the presence of a novel chimerical transcript-the in-frame fusion between EWSR1 exon 7 and ATF1 exon 6 that represents the fourth in-frame type of EWSR1/ATF1 fusion identified in clear cell sarcomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886438     DOI: 10.1007/s00428-012-1295-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

1.  CLEAR-CELL SARCOMA OF TENDONS AND APONEUROSES. AN ANALYSIS OF 21 CASES.

Authors:  F M ENZINGER
Journal:  Cancer       Date:  1965-09       Impact factor: 6.860

2.  Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation.

Authors:  Arturas Jakubauskas; Vilma Valceckiene; Kristina Andrekute; Dmitrij Seinin; Arvydas Kanopka; Laimonas Griskevicius
Journal:  Exp Mol Pathol       Date:  2010-12-24       Impact factor: 3.362

3.  Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center.

Authors:  P Argani; E J Perlman; N E Breslow; N G Browning; D M Green; G J D'Angio; J B Beckwith
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

Review 4.  Clear cell sarcoma of tendons and aponeuroses: a review.

Authors:  Daniel C Dim; Linda D Cooley; Roberto N Miranda
Journal:  Arch Pathol Lab Med       Date:  2007-01       Impact factor: 5.534

5.  Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).

Authors:  Wei-Lien Wang; Empar Mayordomo; Wenyong Zhang; Vivian S Hernandez; Daniel Tuvin; Lisa Garcia; Dina C Lev; Alexander Jf Lazar; Dolores López-Terrada
Journal:  Mod Pathol       Date:  2009-06-26       Impact factor: 7.842

6.  Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas.

Authors:  Ke Yang; Weng-Onn Lui; Yuntao Xie; Anju Zhang; Björn Skytting; Nils Mandahl; Catharina Larsson; Olle Larsson
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

Review 7.  Transcription factors 1: bZIP proteins.

Authors:  H C Hurst
Journal:  Protein Profile       Date:  1995

8.  Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.

Authors:  Ioannis Panagopoulos; Fredrik Mertens; Maria Dêbiec-Rychter; Margareth Isaksson; Janusz Limon; Iwona Kardas; Henryk A Domanski; Raf Sciot; Danuta Perek; Sead Crnalic; Olle Larsson; Nils Mandahl
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

Review 9.  Molecular pathology of sarcomas: concepts and clinical implications.

Authors:  Judith V M G Bovée; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-09-29       Impact factor: 4.064

10.  NCBI BLAST: a better web interface.

Authors:  Mark Johnson; Irena Zaretskaya; Yan Raytselis; Yuri Merezhuk; Scott McGinnis; Thomas L Madden
Journal:  Nucleic Acids Res       Date:  2008-04-24       Impact factor: 16.971

  10 in total
  1 in total

1.  Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.

Authors:  Vivek Subbiah; Oliver Holmes; Kyle Gowen; Daniel Spritz; Behrang Amini; Wei-Lien Wang; Alexa B Schrock; Funda Meric-Bernstam; Ralph Zinner; Sarina Piha-Paul; Maria Zarzour; Julia A Elvin; Rachel L Erlich; David L Stockman; Jo-Anne Vergilio; James H Suh; Philip J Stephens; Vincent Miller; Jeffrey S Ross; Siraj M Ali
Journal:  Oncology       Date:  2016-10-21       Impact factor: 2.935

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.